Back

Library docking for Cannabinoid-2 Receptor ligands

Rachman, M. M.; Iliopoulos-Tsoutsouvas, C.; Dominic Sacco, M.; Xu, X.; Wu, C.-G.; Santos, E.; Glenn, I. S.; Paris, L.; Cahill, M. K.; Ganapathy, S.; Tummino, T. A.; Moroz, Y. S.; Radchenko, D. S.; Okorie, M.; Tawfik, V. L.; Irwin, J. J.; Makriyannis, A.; Skiniotis, G.; Shoichet, B. K.

2026-03-21 biochemistry
10.64898/2026.03.19.713017 bioRxiv
Show abstract

Cannabinoid receptors are therapeutically promising GPCRs that are also interesting test systems for structure-based methods, which have targeted them previously. Here we used the CB2 receptor as a template to explore several topical questions in library docking. Whereas an earlier campaign against the CB1 receptor led to potent but relatively non-selective ligands, here we found that targeting interactions with polar, orthosteric site residues led to subtype-selective ligands. Docking hit rate and especially hit affinity improved in moving from a 7 million to a 2.6 billion molecule library. Similar to earlier studies, docking against active and inactive states of the receptor did not reliably bias toward the discovery of agonists or inverse agonists. Cryo-EM structures of two of the new agonists, each in a different chemotype, superposed well on the docking predictions. Correspondingly, structure-based optimization led to 10- to 140-fold improvements within three different series, also consistent with well-behaved ligand families. Hit rates with a fully enumerated 2.6 billion molecule library resembled those of an implied 11 billion molecule library from a building-block method, consistent with the latters ability to explore this space, though higher affinities were discovered from the fully enumerated set. Overall, eight diverse families of ligands, with potencies <100 nM and mostly unrelated to previously known ligands were found. Implications for future studies are considered.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Journal of Chemical Information and Modeling
207 papers in training set
Top 0.2%
22.8%
2
eLife
5422 papers in training set
Top 8%
8.5%
3
Journal of Medicinal Chemistry
68 papers in training set
Top 0.1%
6.5%
4
Structure
175 papers in training set
Top 0.4%
6.4%
5
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 17%
4.0%
6
PLOS ONE
4510 papers in training set
Top 37%
3.7%
50% of probability mass above
7
Scientific Reports
3102 papers in training set
Top 35%
3.6%
8
PLOS Computational Biology
1633 papers in training set
Top 12%
2.6%
9
Chemical Science
71 papers in training set
Top 0.6%
2.1%
10
Nature Communications
4913 papers in training set
Top 49%
1.8%
11
ChemMedChem
15 papers in training set
Top 0.3%
1.7%
12
International Journal of Molecular Sciences
453 papers in training set
Top 7%
1.7%
13
Communications Biology
886 papers in training set
Top 9%
1.7%
14
ACS Medicinal Chemistry Letters
16 papers in training set
Top 0.3%
1.7%
15
Protein Engineering, Design and Selection
14 papers in training set
Top 0.1%
1.5%
16
Frontiers in Molecular Biosciences
100 papers in training set
Top 2%
1.3%
17
Journal of the American Chemical Society
199 papers in training set
Top 3%
1.3%
18
Proteins: Structure, Function, and Bioinformatics
82 papers in training set
Top 0.6%
1.2%
19
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.6%
1.1%
20
Protein Science
221 papers in training set
Top 1%
1.1%
21
ACS Chemical Biology
150 papers in training set
Top 1%
1.0%
22
Open Biology
95 papers in training set
Top 1%
0.9%
23
Cell Chemical Biology
81 papers in training set
Top 3%
0.9%
24
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.8%
25
Journal of Cheminformatics
25 papers in training set
Top 0.5%
0.8%
26
Frontiers in Chemistry
14 papers in training set
Top 0.3%
0.8%
27
PLOS Biology
408 papers in training set
Top 19%
0.8%
28
Cell Reports
1338 papers in training set
Top 33%
0.8%
29
Communications Chemistry
39 papers in training set
Top 1%
0.7%
30
Journal of Molecular Biology
217 papers in training set
Top 5%
0.5%